histopathology results of primary eyelid tumors
Clicks: 194
ID: 141493
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
4.8
/100
16 views
16 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Objective: To evaluate the histopathological results of
cases who presented with an eyelid mass and underwent
mass excision.
Methods: The histopathological results of 107 cases,
who underwent eyelid mass excision between May 2011
and March 2014 were retrospectively analyzed. Age and
sex, mass localization, operative technique, and histopathological
results were recorded.
Results: Of 107 subjects included in the study, 61 were
male and 46 were female, with a mean age of 49.44±19.81
years. The distribution of benign eyelid tumors were as
follows: 37 (37.8%) squamous papillomas, 19 (19.4%) intradermal
nevus, 9 (9.2%) seborrheic keratosis, 7 (7.1%)
epidermal inclusion cyst, 6 (6.1%) inflammatory lesions, 5
(5.1%) suderiferous cysts, 5 (5.1%) capillary hemangiomas,
3 (3.1%) xanthelasma, 3 (3.1%) fibromas, 1 (1.0%)
moll gland cyst, 1 (1.0%) chondroid syringoma, 1 (1.0%)
dermoid cyst, and 1 (1.0%) actinic keratosis. Malignant
eyelid tumors included 8 (88.9%) cases of basal cell carcinomas
and 1 (11.1%) squamous cell carcinoma.
Conclusion: In this study squamous papilloma was the
most common benign eyelid tumor followed by intradermal
nevus. Basal cell carcinoma was the most common
malignant eyelid tumor followed by squamous cell carcinoma.
| Reference Key |
kurt2015diclehistopathology
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Ali Kurt;Sait Nafiz Mutlu;Halil İbrahim Yener;Nurettin Bayram;Sinan Nazlım |
| Journal | journal of sulfur chemistry |
| Year | 2015 |
| DOI |
10.5798/diclemedj.0921.2015.01.0533
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.